Abstract
Purpose
To investigate the clinical outcomes of Ahmed glaucoma valve (AGV) implantation in primary open-angle glaucoma (POAG) and pseudoexfoliative glaucoma (PEXG).
Methods
The patients who underwent AGV implantation for POAG and PEXG between January 2015 and December 2021 in a single tertiary center eye clinic were reviewed retrospectively. Thirty-one eyes with the diagnosis of POAG constituted Group 1 and 40 eyes with the diagnosis of PEXG constituted Group 2. The primary outcome measures were intraocular pressure (IOP) changes after AGV implantation and surgical success at the last visit. We evaluated complete and qualified surgical success using the following three criteria: (1) IOP ≤ 21mmH g, (2) IOP ≤ 18 mmHg, and (3) IOP ≤ 15 mmHg, as well as the absence of any serious complications, such as light perception loss and phthisis bulbi, and additional de novo glaucoma surgery.
Results
The mean follow-up times were 25.2 (± 21.4) months and 27.6 (± 19.8) months for Groups 1 and 2, respectively (p > 0.05). In Groups 1 and 2, the mean preoperative IOPs were 31.9 ± 9.4 mmHg and 32.3 ± 8.4 mmHg, respectively, which significantly reduced to 14.5 ± 0.7 mmHg and 11.6 ± 0.6 mmHg, respectively at the last postoperative visit (p < 0.001 for both). The mean IOP value at the last visit was statistically significantly lower in Group 2 (p = 0.006). At the last visit, the number of eyes with qualified success according to criteria 1, 2, and 3 was 26 (83.9%), 25 (80.6%), and 18 (58.1%), respectively, in Group 1 and 39 (97.5%), 39 (97.5%), and 32 (80%), respectively, in Group 2. The comparison of the qualified success rates showed statistically significantly higher rates in Group 2 for criterion 2 (p = 0.038).
Conclusion
AGV implantation had high success rates in both POAG and PEXG, but at the final visit, lower IOP levels were reached in the latter.
Similar content being viewed by others
Data availability
The data used in this study are available from the corresponding author upon request.
References
Ritch R, Schlötzer-Schrehardt U (2001) Exfoliation syndrome. Surv Ophthalmol 45(4):265–315
Henry JC, Krupin T, Schmitt M et al (1987) Long-term follow-up of pseudoexfoliation and the development of elevated intraocular pressure. Ophthalmology [Internet] 94(5):545–552. https://doi.org/10.1016/S0161-6420(87)33413-X
Vesti E, Kivela T (2000) Exfoliation syndrome and exfoliation glaucoma. Prog Retin Eye Res 19(3):345–368
Pose-Bazarra S, López-Valladares MJ, López-de-Ullibarri I et al (2021) Surgical and laser interventions for pseudoexfoliation glaucoma systematic review of randomized controlled trials. Eye [Internet] 35(6):1551–1561. https://doi.org/10.1038/s41433-021-01424-1
Coleman AL (2012) Advances in glaucoma treatment and management: Surgery. Investig Ophthalmol Vis Sci 53(5):2491–2494
Bar-David L, Blumenthal EZ (2018) Evolution of glaucoma surgery in the last 25 years. Rambam Maimonides Med J 9(3):e0024
Broadway DC, Chang LP (2001) Trabeculectomy, risk factors for failure and the preoperative state of the conjunctiva. J Glaucoma 10(3):237–249
Ramulu PY, Corcoran KJ, Corcoran SL et al (2007) Utilization of various glaucoma surgeries and procedures in medicare beneficiaries from 1995 to 2004. Ophthalmology 114(12):2265–2271
Gedde SJ, Schiffman JC, Feuer WJ et al (2005) The tube versus trabeculectomy study: design and baseline characteristics of study patients. Am J Ophthalmol 140(2):275.e1-275.e14
Gedde S, Anderson D, Budenz D et al (2012) The tube versus trabeculectomy study: interpretation of results and application to clinical practice. Curr Opin Ophthalmol 23(2):118–126
Kugu S, Erdogan G, Sevim MS et al (2015) Efficacy of long scleral tunnel technique in preventing ahmed glaucoma valve tube exposure through conjunctiva. Semin Ophthalmol 30(1):1–5
Tsai JC, Budenz DL (2017) Five-year pooled data analysis of the Ahmed Baerveldt comparison study and the Ahmed versus Baerveldt study. Am J Ophthalmol [Internet] 176:118–126. https://doi.org/10.1016/j.ajo.2017.01.003
Nouri-Mahdavi K, Hoffman D, Coleman AL et al (2004) Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study. Ophthalmology 111(9):1627–1635
Gaasterland DE, Blackwell B, Ederer F et al (2004) The advanced glaucoma intervention study (AGIS): 13. Comparison of treatment outcomes within race—10-year results. Ophthalmology 111(4):651–664
Gaasterland DE, Ederer F, Beck A et al (2000) The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol. https://doi.org/10.1016/S0002-9394(00)00538-9
Xie Z, Liu H, Du M et al (2019) Efficacy of ahmed glaucoma valve implantation on neovascular glaucoma. Int J Med Sci 16(10):1371–1376
Ong SC, Aquino MC, Chew P et al (2020) Surgical outcomes of a second Ahmed glaucoma valve implantation in Asian eyes with refractory glaucoma. J Ophthalmol 2020:8741301. https://doi.org/10.1155/2020/8741301
Satana B, Yalvac IS, Sungur G et al (2015) Ahmed glaucoma valve implantation for uveitic glaucoma secondary to Behçet disease. J Glaucoma 24(8):607–612
Bao N, Jiang ZX, Coh P et al (2018) Long-term outcomes of uveitic glaucoma treated with Ahmed valve implant in a series of Chinese patients. Int J Ophthalmol 11(4):629–634
Pakravan M, Esfandiari H, Yazdani S et al (2019) Clinical outcomes of Ahmed glaucoma valve implantation in pediatric glaucoma. Eur J Ophthalmol 29(1):44–51
Kang YK, Shin JP, Kim DW (2022) Long-term surgical outcomes of Ahmed valve implantation in refractory glaucoma according to the type of glaucoma. BMC Ophthalmol [Internet] 22(1):1–9. https://doi.org/10.1186/s12886-022-02493-w
Choo JQH, Chen ZD, Koh V, Liang S, Aquino CM, Sng C et al (2018) Outcomes and complications of Ahmed tube implantation in Asian Eyes. J Glaucoma 27(8):733–738
Ayyala RS, Zurakowski D, Smith JA et al (1998) A clinical study of the Ahmed glaucoma valve implant in advanced glaucoma. Ophthalmology 105(10):1968–1976
Elhefney E, Mokbel T, Abou Samra W et al (2018) Long-term results of Ahmed glaucoma valve implantation in Egyptian population. Int J Ophthalmol 11(3):416–421
Sarkisian SR (2009) Tube shunt complications and their prevention. Curr Opin Ophthalmol 20(2):126–130
Erçalık NY, İmamoğlu S (2018) Ahmed glaucoma valve implantation in vitrectomized eyes. J Ophthalmol 2018:9572805. https://doi.org/10.1155/2018/9572805
Mitchell P, Wang JJ, Smith W (1997) Association of pseudoexfoliation syndrome with increased vascular risk. Am J Ophthalmol [Internet] 124(5):685–687. https://doi.org/10.1016/S0002-9394(14)70908-0
Landers J, Martin K, Sarkies N et al (2012) A twenty-year follow-up study of trabeculectomy: risk factors and outcomes. Ophthalmology 119(4):694–702
Li F, Tang G, Zhang H et al (2020) The effects of trabeculectomy on pseudoexfoliation glaucoma and primary open-angle glaucoma. J Ophthalmol 2020:1723691. https://doi.org/10.1155/2020/1723691
Okeke CO, Miller-Ellis E, Rojas M (2017) Trabectome success factors. Medicine (Baltimore) [Internet] 96(24):7061
Hengerer FH, Auffarth GU, Riffel C et al (2018) Prospective, non-randomized, 36-month study of second-generation trabecular micro-bypass stents with phacoemulsification in eyes with various types of glaucoma. Ophthalmol Ther [Internet] 7(2):405–415. https://doi.org/10.1007/s40123-018-0152-8
Quigley HA (2019) 21st century glaucoma care. Eye [Internet] 33(2):254–260. https://doi.org/10.1038/s41433-018-0227-8
Musch DC, Gillespie BW, Lichter PR et al (2009) Visual field progression in the collaborative initial glaucoma treatment study. The impact of treatment and other baseline factors. Ophthalmology [Internet]. 116(2):200-207.e1. https://doi.org/10.1016/j.ophtha.2008.08.051
Funding
The authors received no financial support for the research, authorship, and/or publication of this article.
Author information
Authors and Affiliations
Contributions
YU and SI were responsible for the study design, data acquisition, and analysis. YU wrote the manuscript. Both authors critically revised the manuscript and approved the final version.
Corresponding author
Ethics declarations
Conflicts of interest
The authors declare that there are no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Un, Y., Imamoglu, S. Clinical outcomes of Ahmed glaucoma valve implantation in primary open-angle glaucoma and pseudoexfoliative glaucoma. Int Ophthalmol 44, 25 (2024). https://doi.org/10.1007/s10792-024-02918-z
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10792-024-02918-z